Mental Health

After its RELYVRIO setback, Amylyx's next-gen ALS drug AMX0114 clears a key safety hurdle. Is this the strategic pivot investors have been waiting for?

A new federal investment aims to tackle the hidden crisis of violence against disabled women by scaling a support model built on shared experience.

The PAS 2026 meeting is more than a conference; it's a convergence of science, capital, and community, signaling major shifts in pediatric care.

A new book on stuttering highlights a growing trend: using storytelling as a powerful, low-tech innovation to foster empathy and address childhood health.

Millions of Americans face a 114% average premium hike as ACA tax credits expire. A new poll shows many may drop coverage, risking a public health crisis.